21:00 IST
NSE
Dividend
Remus Pharmaceuticals Dividend
Remus Pharmaceuticals Limited has fixed September 22, 2026, as the record date for determining shareholder entitlement to a final dividend of Rs. 0.50 per share.
Remus Pharmaceuticals Ltd
- Share price
- ₹946.00
- Market cap
- ₹1,115 Cr
- Revenue (annual)
- ₹853.6 Cr
- Net profit (annual)
- ₹36.99 Cr
- P/E (TTM)
- 30.1×Sector 50.4×
- Promoter holding
- 70.95%
- FII holding
- 5.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
SME to Main Board Migration 1Merger & Restructuring 1Management Change 1Dividend 1Annual General Meeting 1
Time
5 announcements with these filters
14:10 IST
NSE
Annual General Meeting
Remus Pharmaceuticals Annual General Meeting
Remus Pharmaceuticals Limited has issued a postal ballot notice seeking shareholder approval for the migration of its equity shares from the NSE Emerge platform to Main Board.
18:38 IST
NSE
Merger & Restructuring
Remus Pharmaceuticals Merger & Restructuring
Remus Pharmaceuticals will incorporate a new subsidiary in the Dominican Republic for pharmaceutical distribution. The company will hold at least 51% of its share capital.
18:36 IST
NSE
Management Change
Remus Pharmaceuticals Management Change
Remus Pharmaceuticals Limited has appointed Mr. Ashutosh Naginbhai Valani as a Non-Executive Independent Director, effective September 2, 2026.
18:29 IST
NSE
SME to Main Board Migration
Remus Pharmaceuticals SME to Main Board Migration
Remus Pharmaceuticals' board approved the company's migration from the NSE SME Emerge platform to the Main Board. It also announced a new subsidiary in the Dominican Republic.